Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

David Einhorn’s Favorite Hedge Fund Managers

David Einhorn’s favorite hedge fund managers are Howard Marks and Bruce Karsh. Greenlight Capital filed a 13G on Monday, disclosing a 1.68 million share position in Howard Marks’ Oaktree Capital (OAK). Einhorn’s $70 million investment in the company gives him a 5.5% stake in Oaktree Capital.

OAKTREE CAPITAL MANAGEMENT

Oaktree Capital sold nearly 9 million shares at $43 on April 12 and started to decline for the next two weeks. Einhorn probably decided to build a large position in OAK  after seeing a lower than expected IPO price and the subsequent decline in the stock. Currently Oaktree is trading at $41.7. Investors can buy the shares at a 3% discount to its IPO price and join David Einhorn.

Russell Hawkins’ Hawkins Capital was even more bullish than David Einhorn. According to Hawkins Capital’s latest 13F, the long/short hedge fund had a 3 million share position in Oaktree.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.